Cross Country Healthcare, Inc. (CCRN) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$10.11
Price Target
$10.61
Target Range
$8.65 — $14.00
Analyst Rating
Hold
Forward P/E103.4x
Trailing P/E-3.5x
Forward PEG—
Implied Growth+103.3%
Median Target$10.50
Analyst Spread50.4%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$9
-14.4%
Consensus
$11
+4.9%
Bull Case
$14
+38.5%
CCRN Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Cross Country Healthcare, Inc. (CCRN) has a Wall Street consensus price target of $10.61, based on estimates from 14 covering analysts. With the stock currently trading at $10.11, this represents a potential upside of +4.9%. The company has a market capitalization of $326M.
Analyst price targets range from a low of $8.65 to a high of $14.00, representing a 50% spread in expectations. The median target of $10.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,10 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CCRN trades at a trailing P/E of -3.5x and forward P/E of 103.4x. Analysts expect EPS to grow +103.3% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+20.3%
Avg Forward P/E17.9x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AMNAMN Healthcare Services, Inc. | $811M | $20.98 | $22.50 | +7.3% | Buy | 10.3x | 17 |
 TBITrueBlue, Inc. | $182M | $6.05 | $5.75 | -5.0% | Buy | — | 10 |
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.07 | $24.50 | +11.0% | Hold | 20.6x | 15 |
 KELYAKelly Services, Inc. | $345M | $9.79 | $15.00 | +53.2% | Buy | 11.1x | 5 |
 MANManpowerGroup Inc. | $1.4B | $29.27 | $37.86 | +29.3% | Hold | 8.0x | 29 |
 ASGNASGN Incorporated | $895M | $20.96 | $37.60 | +79.4% | Hold | 5.8x | 13 |
 KFYKorn Ferry | $3.4B | $66.00 | $70.00 | +6.1% | Buy | 12.4x | 11 |
 HIMSHims & Hers Health, Inc. | $6.9B | $26.88 | $29.67 | +10.4% | Hold | 53.9x | 19 |
 PINCPremier, Inc. | $2.3B | $28.26 | $28.25 | -0.0% | Hold | 20.8x | 31 |
 TDOCTeladoc Health, Inc. | $1.2B | $6.80 | $7.58 | +11.5% | Hold | — | 42 |
Upside Potential Comparison
ASGNKELYAMANTDOCHCSGHIMSAMNKFYSee CCRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCRN — Frequently Asked Questions
Quick answers to the most common questions about buying CCRN stock.
What is the CCRN stock price target for 2026?
The consensus price target for CCRN is $10.61, close to the current price of $10.11 (4.9% implied move). Based on 14 analyst estimates, the stock appears fairly valued near current levels.
Is CCRN a buy, sell, or hold?
CCRN has a consensus rating of "Hold" based on 14 Wall Street analysts. The rating breakdown is mixed, with 10 Hold ratings making up the largest segment. The consensus 12-month price target of $10.61 implies 4.9% upside from current levels.
Is CCRN stock overvalued or undervalued?
At a forward P/E of 103.3742x, CCRN trades at a premium valuation. The consensus price target of $10.61 (4.9% upside) suggests analysts may view current valuations as stretched.
How high can CCRN stock go?
The most bullish Wall Street analyst has a price target of $14 for CCRN, while the most conservative target is $8.65. The consensus of $10.61 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover CCRN stock?
CCRN is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 10 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CCRN stock forecast?
The 12-month CCRN stock forecast based on 14 Wall Street analysts shows a consensus price target of $10.61, with estimates ranging from $8.65 (bear case) to $14 (bull case). The median consensus rating is "Hold".
What is CCRN's forward P/E ratio?
CCRN trades at a forward P/E ratio of 103.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CCRN stock?
CCRN appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $10.61 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CCRN price targets vary so much?
CCRN analyst price targets range from $8.65 to $14, a 50% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $10.61 consensus represents the middle ground.